AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Key drivers include strategic alliances and mergers amongst pharmaceutical firms. The global antibiotics market is projected ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...